| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,739 |
2,587 |
$1.28M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,196 |
6,915 |
$1.07M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
688 |
622 |
$348K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
727 |
704 |
$88K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
338 |
310 |
$56K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
122 |
108 |
$49K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
822 |
785 |
$39K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,438 |
3,923 |
$39K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
204 |
92 |
$36K |
| 87430 |
|
1,068 |
1,043 |
$29K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
266 |
262 |
$26K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
490 |
468 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
490 |
468 |
$24K |
| 87428 |
|
447 |
434 |
$22K |
| 80053 |
Comprehensive metabolic panel |
2,020 |
1,800 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
440 |
399 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
190 |
151 |
$18K |
| 76818 |
|
99 |
49 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
113 |
109 |
$10K |
| 83655 |
|
464 |
461 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
340 |
315 |
$8K |
| 87081 |
|
670 |
653 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
28 |
28 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
501 |
436 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
74 |
69 |
$5K |
| 76801 |
|
34 |
25 |
$4K |
| 86703 |
|
201 |
193 |
$4K |
| 59025 |
Fetal non-stress test |
19 |
12 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
70 |
66 |
$3K |
| 86803 |
|
127 |
120 |
$2K |
| 81003 |
|
966 |
623 |
$2K |
| 81001 |
|
712 |
641 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
19 |
17 |
$2K |
| 87807 |
|
70 |
68 |
$2K |
| 84439 |
|
138 |
126 |
$2K |
| 85018 |
|
330 |
330 |
$1K |
| 84702 |
|
41 |
32 |
$979.22 |
| 87340 |
|
66 |
65 |
$927.56 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
46 |
46 |
$815.71 |
| 83020 |
|
40 |
37 |
$736.64 |
| 86592 |
|
122 |
118 |
$720.52 |
| 84703 |
|
79 |
76 |
$657.11 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16 |
15 |
$652.92 |
| 94760 |
|
14 |
12 |
$579.22 |
| 86850 |
|
16 |
12 |
$468.10 |
| 87070 |
|
44 |
44 |
$447.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
33 |
30 |
$331.76 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16 |
15 |
$316.17 |
| 82105 |
|
12 |
12 |
$312.46 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15 |
14 |
$300.42 |
| 82950 |
|
42 |
38 |
$283.78 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25 |
24 |
$237.07 |
| 83735 |
|
29 |
28 |
$227.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$222.30 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
30 |
27 |
$211.97 |
| 85027 |
|
16 |
15 |
$152.97 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
14 |
13 |
$150.51 |
| 36415 |
Collection of venous blood by venipuncture |
7,420 |
6,089 |
$149.44 |
| 84484 |
|
54 |
40 |
$137.69 |
| 81015 |
|
44 |
40 |
$136.62 |
| 83690 |
|
13 |
13 |
$124.65 |
| 85014 |
|
29 |
29 |
$105.48 |
| 87210 |
|
14 |
12 |
$96.14 |
| 85007 |
|
18 |
17 |
$89.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$87.65 |
| 81025 |
|
13 |
12 |
$70.50 |
| 86901 |
|
16 |
12 |
$49.06 |
| 86900 |
|
16 |
12 |
$49.06 |
| 85610 |
|
13 |
12 |
$35.52 |
| 0031A |
|
25 |
25 |
$28.39 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$7.93 |
| 36416 |
|
676 |
641 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
72 |
63 |
$0.00 |